Advisory Committee Meeting; Amendment of Notice

Özet

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Cardiovascular and Renal Drugs Advisory Committee. This meeting was announced in the Federal Register of September 18, 1997. The amendment is being made to: Remove the second agenda item scheduled on October 23, 1997; add a closed session to the agenda scheduled on October 23, 1997; and provide a new location site for this closed session. There are no other changes. This amendment will be announced at the beginning of the open portion of the meeting.